Get started
Author

J.J. Burgi

Observed names: Burgi, J.J., Bürgi, J., Bürgi, Justus J., J Bürgi, J. Bürgi, J. J. Bürgi, Justus Burgi, Justus Bürgi, Justus J. Bürgi, Justus J. Bürgi
Observed institutions: University of Bern, University of Zurich, Kantonsspital St. Gallen, Natural and Medical Sciences Institute, Zentrum für Labormedizin, University of Tübingen
ORCID: 0000-0003-4210-0061
Observed ORCID: 0000-0003-4210-0061
OpenAlex ID: A5008056628
Unprecedented Selectivity via Electronic Substrate Recognition in the 1,4‐Addition to Cyclic Olefins Using a Chiral Disulfoxide Rhodium Catalyst
2009 · Justus J. Bürgi, Ronaldo Mariz, et al. · Angewandte Chemie International Edition · 102
C2‐Symmetric Chiral Disulfoxide Ligands in Rhodium‐Catalyzed 1,4‐Addition: From Ligand Synthesis to the Enantioselection Pathway
2010 · Ronaldo Mariz, Albert Poater, et al. · Chemistry - A European Journal · 59
Discovery of α7-Nicotinic Receptor Ligands by Virtual Screening of the Chemical Universe Database GDB-13
2011 · Lorenz C. Blum, Ruud van Deursen, et al. · Journal of Chemical Information and Modeling · 33
Discovery of Potent Positive Allosteric Modulators of the α3β2 Nicotinic Acetylcholine Receptor by a Chemical Space Walk in ChEMBL
2014 · Justus J. Bürgi, Mahendra Awale, et al. · ACS Chemical Neuroscience · 23
Unprecedented Selectivity via Electronic Substrate Recognition in the 1,4‐Addition to Cyclic Olefins Using a Chiral Disulfoxide Rhodium Catalyst
2009 · Justus J. Bürgi, Ronaldo Mariz, et al. · Angewandte Chemie · 21
Systemic and T cell‐associated responses to SARS‐CoV ‐2 immunisation in gut inflammation ( STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS‐CoV ‐2
2022 · Simon Woelfel, Joel Dütschler, et al. · Alimentary Pharmacology & Therapeutics · 19
XBB .1.5‐Adapted COVID ‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS ‐ CoV ‐2 JN .1 Variant in Patients With Inflammatory Bowel Disease
2024 · Simon Woelfel, Joel Dütschler, et al. · Alimentary Pharmacology & Therapeutics · 15
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
2023 · Simon Woelfel, Joel Dütschler, et al. · Alimentary Pharmacology & Therapeutics · 14
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
2024 · Simon Woelfel, Joel Dütschler, et al. · Vaccines · 12
Mild COVID-19 induces early, quantifiable, persistent troponin I elevations in elder men
2022 · Justus J. Bürgi, Matthias Rösslein, et al. · Frontiers in Cardiovascular Medicine · 11
PDF
Understanding the kinetics of macrophage uptake and the metabolic fate of iron-carbohydrate complexes used for iron deficiency anemia treatment
2025 · Stephanie Eitner, Vera M. Kissling, et al. · Journal of Controlled Release · 8
Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time – indication of persistence of the virus?
2021 · Justus J. Bürgi, Matthias Rösslein, et al. · Journal of Infection · 6
PDF
Disulfoxide Ligands in Rhodium Catalyzed Asymmetric 1,4-Addition: First Studies and Future Directions
2009 · Ronaldo Mariz, Justus Bürgi, et al. · CHIMIA International Journal for Chemistry · 5
PDF
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease
2024 · Simon Woelfel, Daniel Junker, et al. · Vaccines · 2
PDF
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease
2025 · Simon Woelfel, Joel Dütschler, et al. · Vaccines · 1
PDF
Pos1115 Lower Cd169 Expression on Monocytes in Urine Than on Monocytes in Peripheral Blood Indicates Severity of Renal Involvement in Sle Patient
2024 · L. Böni, K. Schmiedeberg, et al. · Annals of the Rheumatic Diseases · 1
Fluorescent Agonists of the α7 Nicotinic Acetylcholine Receptor Derived from 3‐Amino‐Quinuclidine
2016 · Justus J. Bürgi, Sonia Bertrand, et al. · Helvetica Chimica Acta · 1
Postpartum Hemorrhage in a Large Prospective Cohort Study: Is Uterine Atony really the Main Culprit?
2026 · Wolfgang Korte, Torsten HOTHORN, et al. · medRxiv
PDF
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH
2025 · W Korte, J Bürgi, et al. · Hämostaseologie
Post Partum Haemorrhage (PPH): Time to Change Perception of Pathophysiology and Approach to Therapy? Uterine Atony in Developing PPH Is Rare with Disturbances of Coagulation Being Early and Frequent
2024 · Wolfgang Korte, Justus Bürgi, et al. · Blood
Correlation of factor XIII subunit A with factor XIII activity in a population of parturient women
2024 · M. L. Frevert, J. Bürgi, et al. · Archives of Gynecology and Obstetrics
PDF
CCDC 1404503: Experimental Crystal Structure Determination
2016 · Bürgi, Justus J., Bertrand, Sonia, et al. · The Cambridge Structural Database
CCDC 1404502: Experimental Crystal Structure Determination
2016 · Bürgi, Justus J., Bertrand, Sonia, et al. · The Cambridge Structural Database
Discovery of nicotinic acetylcholine receptor ligands in the chemical universe database GDB-13
2011 · L.C. Blum, R. van Deursen, et al. · Biochemical Pharmacology
New carbon- and sulfur-based ligands in late-transition metal catalysis
2011 · Mariz Ronaldo, Xinjun Luan, et al.
Works count: 46
Citation count: 333
H-index: 10
I10-index: 10
Year
Topic
Type